Microbial Lv-Rsn-1 Surfactant Protein Production Without Extractivism
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
The industrial production of biosurfactants, particularly surfactant proteins like Lv-Rsn-1 from the Northeastern Pepper Frog, is hindered by high manufacturing costs, low yield, and ethical-legal issues with extractivism, making it difficult to achieve commercialization and widespread application.
Innovation Solution
Development of genetically modified bacteria and yeast that heterologously produce modified versions of Lv-Rsn-1 surfactant protein using optimized synthetic genes and expression vectors, enabling efficient production without relying on the frog's foam.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If extractivism is used to obtain Lv-Rsn-1 from frog foam, then the natural surfactant protein can be obtained, but high manufacturing costs and ethical-legal issues arise
Solution Approach 1:
The patent creates synthetic genes that encode modified versions of the Lv-Rsn-1 surfactant protein sequence, which are then expressed in heterologous microorganisms. This copying approach replaces the need for extractivism while maintaining the essential surfactant properties of the original protein.
Solution Approach 2:
The patent uses microorganisms as intermediary production systems. These microorganisms are genetically modified to express the synthetic gene encoding Lv-Rsn-1, serving as a mediator between the desired protein product and the production process, thereby avoiding direct extraction from frogs.
2Reliability
If extractivism is used to obtain Lv-Rsn-1 from frog foam, then the surfactant protein can be obtained, but low yield and difficulty in commercialization occur
Solution Approach 1:
The synthetic gene encoding Lv-Rsn-1 is copied and inserted into microorganisms that can be cultured at scale. This enables production to be decoupled from the limited natural source, allowing for high-yield, scalable manufacturing suitable for commercialization.
Solution Approach 2:
The patent modifies the amino acid sequence of Lv-Rsn-1 to create variants that may have improved expression characteristics in heterologous systems. These parameter changes in the protein sequence facilitate higher yields and better production performance in microbial hosts.
3Productivity
If heterologous production in microorganisms is implemented, then manufacturing cost and scalability are improved, but production of modified versions rather than exact natural sequence occurs
Solution Approach 1:
The patent intentionally modifies the amino acid sequence of the original Lv-Rsn-1 to create variant proteins. These parameter changes in the sequence are designed to maintain or improve surfactant properties while enabling efficient heterologous expression in microorganisms.
Solution Approach 2:
The patent makes localized modifications to specific regions of the Lv-Rsn-1 protein sequence while preserving the overall structure and key functional domains. This allows the protein to maintain its essential surfactant properties while being optimized for microbial production.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
Facilitates the production of a single isoform of Lv-Rsn-1 surfactant protein, overcoming cost and ethical barriers, and demonstrating surfactant activities such as emulsification, surface tension reduction, and dispersancy, suitable for various industrial applications.
Implementation Method 1
Development of genetically modified bacteria and yeast that heterologously produce modified versions of Lv-Rsn-1 surfactant protein using optimized synthetic genes and expression vectors
Implementation Method 2
Surfactants constitute a class of amphiphilic molecules, that is: their molecular structure presents simultaneously a polar portion (hydrophilic and lipophobic) and a nonpolar portion (hydrophobic and lipophilic), and for this reason these molecules have the property of accumulating on the surfaces and interfaces of a system, reducing the free energy of those surfaces and interfaces
Implementation Method 3
These applications explore the different activities of these surface-active molecules, the main ones being: emulsification, de-emulsification, solubilization and detergency
Data Source
AI summary
The present invention refers to the heterologous production in microorganisms of modified versions of a predicted isoform of the surfactant protein Lv-ranaspumin-1 (Lv-Rsn-1), whose sequence was inferred from analyzes of the protein extract of the nest foam from the Northeastern Pepper Frog (Leptodactylus vastus). More specifically, it refers to two surfactant proteins that consist of modified versions of the predicted isoform of Lv-Rsn-1; to two synthetic genes each encoding one of these modified versions of the predicted isoform of Lv-Rsn-1; to two expression cassettes each containing one of the synthetic genes encoding one of the modified versions of the predicted isoform of Lv-Rsn-1; to two expression vectors each containing one of the synthetic genes encoding modified versions of the predicted isoform of Lv-Rsn-1; and to two transgenic microorganisms, a bacterium and a yeast, each transformed with one of these synthetic genes and heterologously producing one of the modified versions of the predicted isoform of Lv-Rsn-1. Lv-Rsn-1 has surfactancy, emulsification and dispersancy properties, among others, and its heterologous production allows it to be used in various applications and industrial products, without the need to extract it from the frog nest foam.